Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Delayed transvenous lead removal may boost risk of tricuspid regurgitation

Increases in tricuspid regurgitation (TR) severity occurred in 11.5 percent of patients following transvenous lead extraction, according to a single-center study, which also identified lead age as an important predictor of acute TR increases and tricuspid valve injury.

Thumbnail

How CV risk factors influence future CHD, stroke rates in women

Cardiovascular risk factors have similar effects on the incidence of coronary heart disease (CHD) and ischemic stroke in women, researchers report in the first large-scale study of its kind in female patients.

OHCA survival varies 1.5-fold from one EMS agency to next

A patient’s odds of surviving out-of-hospital cardiac arrest (OHCA) fluctuate an average of 56 percent from one emergency medical services (EMS) agency to another, researchers reported Sept. 26 in JAMA Cardiology.

Thumbnail

PAD patients with previous revascularization at elevated risk for future CVD events

Patients with peripheral artery disease (PAD) and a history of lower extremity revascularization (LER) face an increased risk of both cardiac and limb ischemic events and subsequent revascularization, according to research published in the Journal of the American College of Cardiology Oct. 2.

Edwards Lifesciences' Philanthropy Exceeds Every Heartbeat Matters Goal To Impact One Million Underserved People Ahead Of Schedule

IRVINE, Calif., Sept. 26, 2018 — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, announced at a 60th anniversary educational event that the Every Heartbeat Matters initiative has exceeded the goal to impact the global burden of heart valve disease by supporting the education, screening and treatment of one million underserved people by 2020.

Thumbnail

'Delicate' hemostasis puts newborns at heightened risk for thrombosis

A Russian study that analyzed the process of blood coagulation in humans at different life stages has found hemostasis in newborn babies is particularly delicate—something that, paired with other common risks, can boost an infant’s risk of thrombosis early in life.

Thumbnail

Swings in metabolic measures linked to cardiovascular events

Metabolic parameters like body weight, blood pressure, cholesterol and blood sugar levels are established risk factors for cardiovascular disease. But a new study suggests it’s not just abnormal measures of these components that portend risk—significant fluctuations in these areas are independently linked to all-cause mortality, heart attack and stroke among otherwise healthy people.

Thumbnail

How vitamin B protects kidney health in kids with T1D

An increased intake of vitamin B, paired with routine ACE inhibitor therapy, could help protect kidney function in kids and teens with type 1 diabetes (T1D), according to a study presented at the 57th annual European Society for Pediatric Endocrinology Meeting in Athens, Greece.